ReShape Lifesciences, Inc. (OBLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1158456,
    "name": "ReShape Lifesciences, Inc.",
    "stock_name": "ReShape Lifesciences, Inc.",
    "full_name": "ReShape Lifesciences, Inc.",
    "name_url": "stocks-analysis/reshape-lifesciences-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.09",
    "chg": 0.13,
    "chgp": "2.72%",
    "dir": 1,
    "prev_price": "4.96",
    "mcapval": "6.70",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US76090R2004",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "6.2 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/reshape-lifesciences-inc-1158456-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is ReShape Lifesciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-reshape-lifesciences-inc-technically-bullish-or-bearish-3548351",
        "imagepath": "",
        "date": "2025-09-20 20:15:31",
        "description": "As of 27 May 2025, the technical trend for ReShape Lifesciences, Inc. has changed from sideways to mildly bearish. The current stance is bearish, driven by daily moving averages indicating bearishness and weekly Bollinger Bands also showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, the overall sentiment is tempered by the Dow Theory and KST both indicating a mildly bearish stance on a weekly basis. The RSI shows no signal on the weekly chart but is bullish on the monthly chart, suggesting some divergence in momentum. \n\nIn terms of performance, the stock has significantly underperformed compared to the S&P 500 across all periods, with a year-to-date return of -98.52% versus the S&P 500's 12.22%...."
      },
      {
        "title": "Is ReShape Lifesciences, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-reshape-lifesciences-inc-overvalued-or-undervalued-3544413",
        "imagepath": "",
        "date": "2025-09-20 18:45:37",
        "description": "As of 16 August 2021, ReShape Lifesciences, Inc. has moved from a grade of \"does not qualify\" to \"risky,\" indicating a significant deterioration in its valuation outlook. The company is overvalued, given its negative financial metrics, including a Price to Book Value of 2.51 and an EV to EBITDA of -0.09. Additionally, the Return on Equity (ROE) stands at a staggering -501.25%, which further underscores the company's financial struggles.\n\nIn comparison to its peers, ReShape Lifesciences exhibits worse performance metrics, with NanoVibronix, Inc. showing a P/E of -0.9426 and EV to EBITDA of -0.2892, while INVO BioScience, Inc. has an EV to EBITDA of -0.6859. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -98.52% compared to the S&P 500's 12.22%, reinforcing the notion that ReShape Lifesciences is not a viable investment at this time...."
      }
    ],
    "total": 7,
    "sid": "1158456",
    "stock_news_url": "https://www.marketsmojo.com/news/reshape-lifesciences-inc-1158456"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is ReShape Lifesciences, Inc. technically bullish or bearish?

2025-09-20 20:15:31

As of 27 May 2025, the technical trend for ReShape Lifesciences, Inc. has changed from sideways to mildly bearish. The current stance is bearish, driven by daily moving averages indicating bearishness and weekly Bollinger Bands also showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, the overall sentiment is tempered by the Dow Theory and KST both indicating a mildly bearish stance on a weekly basis. The RSI shows no signal on the weekly chart but is bullish on the monthly chart, suggesting some divergence in momentum. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across all periods, with a year-to-date return of -98.52% versus the S&P 500's 12.22%....

Is ReShape Lifesciences, Inc. overvalued or undervalued?

2025-09-20 18:45:37

As of 16 August 2021, ReShape Lifesciences, Inc. has moved from a grade of "does not qualify" to "risky," indicating a significant deterioration in its valuation outlook. The company is overvalued, given its negative financial metrics, including a Price to Book Value of 2.51 and an EV to EBITDA of -0.09. Additionally, the Return on Equity (ROE) stands at a staggering -501.25%, which further underscores the company's financial struggles. In comparison to its peers, ReShape Lifesciences exhibits worse performance metrics, with NanoVibronix, Inc. showing a P/E of -0.9426 and EV to EBITDA of -0.2892, while INVO BioScience, Inc. has an EV to EBITDA of -0.6859. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -98.52% compared to the S&P 500's 12.22%, reinforcing the notion that ReShape Lifesciences is not a viable investment at this time....

View All News